Skip to main content

Table 1 The implementation conditions and transfection results of nucleofection in related studies

From: Nucleic acid direct delivery to fibroblasts: a review of nucleofection and applications

Cell type

Species

Passage

Cell confluence

Procedure

Cell viability

Transfection efficiency

Reference

Dermal fibroblasts

Rat

2

80%-90%

U-30

 > 95.00%

·51.50% ± 7.90%

(Standard method)

·80.50% ± 5.00%

(Modified method: DMEM + 10% FCS)

[11]

Dermal fibroblasts

Rat

 ≤ 3

80%-90%

U-30

/

·68.34% ± 10.32% (Standard method)

·85.35% ± 11.56%

(Modified method: DMEM + 10% FCS)

[13]

Dermal fibroblasts

Human

 ≤ 3

80%-90%

U-24

/

·83.88% ± 9.67%

(Standard method)

·57.88% ± 3.45%

(Modified method: DMEM + 10% FCS)

·79.21% ± 1.62%

(Modified method:

ITS supplement)

[13]

Dermal fibroblasts

Human

/

80%-90%

U-20

80.00%-

90.00%

40.00%-50.00%

[14]

Dermal fibroblasts

Pig

3–4

/

V-13

/

60.10%

[19]

Dermal fibroblasts

Rat

2–4

/

U-23

91.10%

72.50%

[20]

Dermal fibroblasts

Human

/

/

U-23

37.00%

10.00%

[23]

Dermal fibroblasts

Human

1–5

/

U-30

T-018

 > 68.70%

34.60%

[28]

Dermal fibroblasts

Pig

/

90%

U-23

V-13

87.90% ± 

7.40%

(U23)/

85.40% ± 

7.50%

(V13)

·80.80% ± 6.20%

(U23)

·86.00% ± 2.50%

(V13)

[30]

Sciatic nerve fibroblasts

Rat

/

80%

T-16

/

80.00%

[31]

Dermal fibroblasts

Rat

/

/

U-23

P-22

/

·57.33% (U-23)

·57.00% (P-22)

[33]

Embryonic fibroblasts

Zebrafish

/

/

O-20

30.00%-

35.00%

35.00%-43.00%

[35]

Fetal fibroblast

Buffalo of Murrah breed

/

70%-80%

EN-150

70.00%-

80.00%

73.60% ± 1.36%

[36]

Fetal fibroblast

Buffalo of Murrah breed

2–3

70%-80%

EN-150

53.80% ± 

4.20%

73.50% ± 1.40%

[41]

Embryo fibroblasts

Pig

16

/

U-20

95.00%

90.00%

[46]

Embryonic ear fibroblasts

Rabbit

/

/

U-23

/

38.00%

[46]

Embryonic fibroblasts

Pig

3–7

/

U-23

57.80%

79.00% ± 0.80%

[48]

Kidney fibroblasts

Pig

/

/

T-007

/

65.00%-70.00%

[49]